Managing costly new drugs to support equitable access: international collaboration and patient engagement to assess value, and managed entry agreements
- DOI
- 10.1136/bmj-2025-086174
- Published
- 2025-11-11
- Container
- BMJ
- Publisher
- BMJ
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1136/bmj-2025-086174,
title = {Managing costly new drugs to support equitable access: international collaboration and patient engagement to assess value, and managed entry agreements},
author = {Tarang Sharma and Krista Kruja and Christine Årdal and Ruth Lopert and Jorge Mestre-Ferrandiz and Simone Boselli and Sabine Vogler},
year = {2025},
journal = {BMJ},
doi = {10.1136/bmj-2025-086174},
url = {https://doi.org/10.1136/bmj-2025-086174}
}RIS
TY - JOUR TI - Managing costly new drugs to support equitable access: international collaboration and patient engagement to assess value, and managed entry agreements AU - Tarang Sharma AU - Krista Kruja AU - Christine Årdal AU - Ruth Lopert AU - Jorge Mestre-Ferrandiz AU - Simone Boselli AU - Sabine Vogler PY - 2025 JO - BMJ DO - 10.1136/bmj-2025-086174 UR - https://doi.org/10.1136/bmj-2025-086174 ER -
APA
Sharma, T., Kruja, K., Årdal, C., Lopert, R., Mestre-Ferrandiz, J., Boselli, S., & Vogler, S. (2025). Managing costly new drugs to support equitable access: international collaboration and patient engagement to assess value, and managed entry agreements. BMJ. https://doi.org/10.1136/bmj-2025-086174
Source records
- crossref · retrieved 2026-11-10T14:45:00.295Z